von Willebrand's disease and menorrhagia: Prevalence, diagnosis, and management
- 24 June 2005
- journal article
- review article
- Published by Wiley in American Journal of Hematology
- Vol. 79 (3), 220-228
- https://doi.org/10.1002/ajh.20372
Abstract
The reported prevalence of von Willebrand's disease (vWD) is increased in women with menorrhagia, with current estimates ranging from 5% to 20%. The consistent results of multiple studies suggest testing should be included in the evaluation of patients with menorrhagia, especially in unexplained cases and prior to surgical intervention. Although a cyclic variation in von Willebrand's factor levels has not been confirmed, several studies suggest lower levels during menses and the early follicular phase. Menorrhagia is one of the most common bleeding manifestations of von Willebrand's disease, reported by 60–95% of women afflicted with this bleeding disorder. Menorrhagia is typically severe, often resulting in anemia and interfering with quality of life. Despite the frequency of menorrhagia, there is no consensus on optimal management. Although oral contraceptives are frequently prescribed, there are no studies confirming their efficacy using objective measures of response. Desmopressin was associated with an 80–92% response rate in several uncontrolled studies relying on patient assessment of efficacy. However, a small, randomized trial found no significant reduction in menstrual blood flow compared with placebo. There are anecdotal reports of the successful use of antifibrinolytic agents alone and in combination with other therapies. There are no studies comparing the relative efficacy and safety of the available medical therapies for von Willebrand's disease associated menorrhagia. Until these studies are completed, treatment should be individualized based on von Willebrand's disease subtype, patient age, contraceptive needs, and personal preference. Am. J. Hematol. 79:220–228, 2005.Keywords
This publication has 74 references indexed in Scilit:
- Testing for von Willebrand Disease in Women With Menorrhagia: A Systematic ReviewObstetrics & Gynecology, 2004
- von Willebrand disease in women with menorrhagia: a systematic reviewBJOG: An International Journal of Obstetrics and Gynaecology, 2004
- Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acidBMJ, 1996
- Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagiaBJOG: An International Journal of Obstetrics and Gynaecology, 1995
- Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathiesBJOG: An International Journal of Obstetrics and Gynaecology, 1991
- Nasal Spray Desmopressin (DDAVP) for Mild Hemophilia A and von Willebrand DiseaseAnnals of Internal Medicine, 1991
- Hemostasis profile in women taking low-dose oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 1990
- Cerebral sinus thrombosis as a potential hazard of antifibrinolytic treatment in menorrhagia.Stroke, 1990
- Acute adolescent menorrhagiaAmerican Journal of Obstetrics and Gynecology, 1981
- Treatment of menorrhagiaAmerican Journal of Obstetrics and Gynecology, 1971